140 related articles for article (PubMed ID: 18038871)
1. Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use.
Martoni AA; Tanneberger S; Mutri V
Tumori; 2007; 93(5):417-22. PubMed ID: 18038871
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy use at the end of life. A retrospective single centre experience analysis.
Andreis F; Rizzi A; Rota L; Meriggi F; Mazzocchi M; Zaniboni A
Tumori; 2011; 97(1):30-4. PubMed ID: 21528660
[TBL] [Abstract][Full Text] [Related]
3. Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care.
Magarotto R; Lunardi G; Coati F; Cassandrini P; Picece V; Ferrighi S; Oliosi L; Venturini M
Tumori; 2011; 97(5):573-7. PubMed ID: 22158486
[TBL] [Abstract][Full Text] [Related]
4. Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?
Dalrymple JL; Levenback C; Wolf JK; Bodurka DC; Garcia M; Gershenson DM
Gynecol Oncol; 2002 May; 85(2):356-61. PubMed ID: 11972400
[TBL] [Abstract][Full Text] [Related]
5. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer.
Fang P; Jagsi R; He W; Lei X; Campbell EG; Giordano SH; Smith GL
J Clin Oncol; 2019 Jul; 37(20):1721-1731. PubMed ID: 31141431
[TBL] [Abstract][Full Text] [Related]
6. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
7. Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer.
Mack JW; Walling A; Dy S; Antonio AL; Adams J; Keating NL; Tisnado D
Cancer; 2015 Jun; 121(11):1891-7. PubMed ID: 25677655
[TBL] [Abstract][Full Text] [Related]
8. Aggressiveness of cancer-care near the end-of-life in Korea.
Keam B; Oh DY; Lee SH; Kim DW; Kim MR; Im SA; Kim TY; Bang YJ; Heo DS
Jpn J Clin Oncol; 2008 May; 38(5):381-6. PubMed ID: 18411260
[TBL] [Abstract][Full Text] [Related]
9. Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006.
Tang ST; Wu SC; Hung YN; Huang EW; Chen JS; Liu TW
Ann Oncol; 2009 Feb; 20(2):343-8. PubMed ID: 18765460
[TBL] [Abstract][Full Text] [Related]
10. The utilization of palliative care in gynecologic oncology patients near the end of life.
Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
[TBL] [Abstract][Full Text] [Related]
11. Family Perspectives on Aggressive Cancer Care Near the End of Life.
Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
[TBL] [Abstract][Full Text] [Related]
12. The rise of concurrent care for veterans with advanced cancer at the end of life.
Mor V; Joyce NR; Coté DL; Gidwani RA; Ersek M; Levy CR; Faricy-Anderson KE; Miller SC; Wagner TH; Kinosian BP; Lorenz KA; Shreve ST
Cancer; 2016 Mar; 122(5):782-90. PubMed ID: 26670795
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Last-line Treatment in Metastatic Breast Cancer.
Cinausero M; Gerratana L; De Carlo E; Iacono D; Bonotto M; Fanotto V; Buoro V; Basile D; Vitale MG; Rihawi K; Fasola G; Puglisi F
Clin Breast Cancer; 2018 Jun; 18(3):205-213. PubMed ID: 28781022
[TBL] [Abstract][Full Text] [Related]
14. Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.
Lammers A; Slatore CG; Fromme EK; Vranas KC; Sullivan DR
J Thorac Oncol; 2019 Feb; 14(2):176-183. PubMed ID: 30336324
[TBL] [Abstract][Full Text] [Related]
15. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
Hashimoto K; Yonemori K; Katsumata N; Hotchi M; Kouno T; Shimizu C; Tamura K; Ando M; Takeuchi M; Fujiwara Y
Oncologist; 2009 Jul; 14(7):752-9. PubMed ID: 19596665
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients.
Massa I; Nanni O; Foca F; Maltoni M; Derni S; Gentili N; Frassineti GL; Casadei Gardini A; Valgiusti M; Amadori D; Prati E; Altini M; Gallegati D; Sansoni E
BMC Palliat Care; 2018 Jun; 17(1):86. PubMed ID: 29914452
[TBL] [Abstract][Full Text] [Related]
17. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis.
Braga S; Miranda A; Fonseca R; Passos-Coelho JL; Fernandes A; Costa JD; Moreira A
Psychooncology; 2007 Sep; 16(9):863-8. PubMed ID: 17245696
[TBL] [Abstract][Full Text] [Related]
18. The Bologna Eubiosia Project: hospital-at-home care for advanced cancer patients.
Pannuti F; Tanneberger S
J Palliat Care; 1992; 8(2):11-7. PubMed ID: 1378893
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
20. Chemotherapy in the last 30 days of life of advanced cancer patients.
Pacetti P; Paganini G; Orlandi M; Mambrini A; Pennucci MC; Del Freo A; Cantore M
Support Care Cancer; 2015 Nov; 23(11):3277-80. PubMed ID: 25900109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
